Abstract:Traditional Chinese medicine(TCM) carries the experience and theoretical knowledge of the ancients, and the use of "toxic" Chinese medicines is a major feature and advantage of TCM. "Toxic" Chinese medicines have unique clinical value and certain medication risk under the guidance of TCM theories such as compatibility for detoxification and treatment based on syndrome differentiation. In recent years, the safety events of Chinese medicines have occurred frequently, which has made the safety of Chinese medicine a public concern in China and abroad. However, limited by conventional cognitive laws and technical methods, basic research on toxicity of Chinese medicines fails to be combined with the clinical application. As a result, it is difficult to identify the clinical characteristics of, predict toxic and side effects of, or form a universal precise medication regimen for "toxic" Chinese medicines, which restricts the clinical application of them. In view of the problem that the toxicity of "toxic" Chinese medicines is difficult to be predicted and restricts the clinical application, the evidence-based research concept will provide new ideas for safe applcation of them in clinical practice. The integrated development of multiple disciplines and techniques in the field of big data and artificial intelligence will also promote the renewal and development of the research models for "toxic" Chinese medicines. Our team tried to propose the academic concept of evidence-based Chinese medicine toxicology and establish the data-intelligence research mode for "toxic" Chinese medicines and the intelligent risk prediction method for medicinal combination in the early stage, which provided methodological supports for solving the above problem. Thus, on the basis of summarizing the research status and problems of the clinical medication regimen of "toxic" Chinese medicines, our team took the evidence-based toxicology of TCM as the core concept, and tried to construct the multiple-evidence integrated evaluation and prediction method for "toxic" Chinese medicine, so as to guide the establishment of the non-toxic medication regimen of "toxic" Chinese medicines. Specifically, through the analysis of multivariate data obtained from the basic research, the evidence-based toxicology database of Chinese medicines and the individualized "toxicity-effect" intelligent prediction platform were built based on the disease-syndrome virtual patients, so as to identify the clinical characteristics and risks of "toxic" Chinese medicines and develop individualized medication regime. This study is expected to provide a methodological reference for the establishment of medication regimen and risk prevention strategy for "toxic" Chinese medicines. The method established in this study will bridge clinical research and basic research, enhance the transformation of the scientific connotation of attenuated compatibility, promote the development of evidence-based Chinese medicine toxicology, and ensure the clinical safety of "toxic" Chinese medicines.

[Key Foundational Science Problem in Experimental Medicine Study of Chinese Materia Medica: Ascertainment of Active and Toxic Constituents from Chinese Materia Medica].

QSAR Study on Toxicity of Chemical Components of Chinese Materia Medica and Acute Toxicity of Rats

Methodology and Applications for Multimodal Identification of Active Constituents of Traditional Chinese Medicine

[Discovery Strategy for Effective and Active Constituents of Chinese Material Medica Based on Processes of Metabolism and Disposition in Intra-Body].

Thinking on Attact Emphasis to Study of Chinese Formulated Products Contained Strong Toxicity

Research Progress and Prospect on the Effective Material Basis and Related Mechanism of Traditional Chinese Medicine Driven by Systematic Thinking

Unraveling the mystery of efficacy in Chinese medicine formula: New approaches and technologies for research on pharmacodynamic substances

Safety Research in Traditional Chinese Medicine: Methods, Applications, and Outlook

Strategies and Approaches on Exploring Material Basis of Chinese Materia Medica

'Risk-benefit' assessment for comprehensive safety evaluation of Chinese patent medicines containing four common toxic ingredients: an analysis of clinical risk factors

The Study and Regulation of Active Ingredients Has Broad Application Prospect in the Production of Chinese Herbal Medicine

Preliminary elaboration on emergent properties of traditional Chinese medicine.

Progression on Studies of Effective Components of Chinese Herbal Compound

[Structural Chinese medicine: new research field on pharmacodynamic substance basis of traditional Chinese medicine]

Deciphering the toxicity-effect relationship and action patterns of traditional Chinese medicines from a smart data perspective: a comprehensive review

[Establishment of multiple evidence-integrated evaluation and prediction method for "toxic" Chinese medicines]

Potential efficacious materials investigation of Yi-Yi Mixture based on Metabolome-oriented network pharmacology strategy

Recent Methods and Strategies for in vivo Metabolic Study of Traditional Chinese Medicines

Current Status and Major Challenges to the Safety and Efficacy Presented by Chinese Herbal Medicine

Study of Chemical Matteromics and Prescription of Traditional Chinese Medicine——And An Analysis of Material Foundation of Compound Prescription Qingkailing

Metabolites Identification and Pharmacokinetic Studies of Chinese Herbal Medicines